New CardioMetAge Clock Predicts Heart Disease Better Than Existing Aging Tests
Scientists created a specialized aging clock using 12 biomarkers that outperforms current tests at predicting cardiovascular disease risk.
Summary
Researchers developed CardioMetAge, a new biological aging clock specifically designed to predict cardiometabolic diseases like heart disease and diabetes. Using chronological age plus 12 common clinical biomarkers, this tool significantly outperformed existing aging clocks at predicting disease risk, mortality, and progression. The study found CardioMetAge was 87% more accurate at predicting cardiometabolic death and 35% better at predicting disease onset. Importantly, lifestyle factors and caloric restriction could slow CardioMetAge progression, with two years of caloric restriction reducing biological age by 1.23 years compared to normal eating.
Detailed Summary
Scientists have created CardioMetAge, a revolutionary biological aging clock that specifically targets cardiometabolic health risks. Unlike existing aging tests that measure general biological aging, this new tool focuses exclusively on predicting heart disease, diabetes, and related conditions that are major drivers of premature death and disability.
Researchers analyzed data from over 100,000 participants across multiple large-scale studies including NHANES and UK Biobank. They developed CardioMetAge using chronological age combined with 12 readily available clinical biomarkers that doctors routinely measure during checkups.
The results were striking. CardioMetAge showed 87% stronger associations with cardiometabolic mortality compared to existing aging clocks like PhenoAge. It was 35% more accurate at predicting disease incidence and significantly better at tracking disease progression from healthy to first diagnosis to multiple conditions. The tool also consistently outperformed traditional models in predicting 10-year disease risk.
Crucially, the research revealed that CardioMetAge responds to interventions. Two years of caloric restriction slowed CardioMetAge progression by 1.23 years compared to normal eating. Lifestyle factors and socioeconomic status influenced cardiometabolic aging, with lifestyle accounting for 34.5% of the effect on disease risk through CardioMetAge.
This specialized aging clock offers unprecedented precision for assessing cardiometabolic health and monitoring intervention effectiveness. Its use of common biomarkers makes it immediately practical for clinical application, potentially revolutionizing how we predict, prevent, and track progress against age-related cardiovascular and metabolic diseases.
Key Findings
- CardioMetAge predicts cardiometabolic death 87% more accurately than existing aging clocks
- Two years of caloric restriction reduced biological aging by 1.23 years versus normal eating
- Lifestyle factors account for 34.5% of disease risk through cardiometabolic aging pathways
- The clock uses only 12 common biomarkers, making it immediately practical for clinical use
Methodology
Researchers analyzed data from NHANES-III for model development and validated results in continuous NHANES and UK Biobank cohorts totaling over 100,000 participants. The study tracked disease outcomes, mortality, and progression over multiple years with rigorous statistical controls.
Study Limitations
The study was observational, limiting causal inferences about aging mechanisms. The model was developed primarily in Western populations, potentially limiting generalizability to other ethnic groups. Long-term validation studies are needed to confirm sustained predictive accuracy.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.